Who Owns Optum?
Optum is owned by UnitedHealth Group, Inc. (NYSE: UNH), a publicly traded American healthcare company headquartered in Minnetonka, Minnesota. Optum was formed in 2011 when UnitedHealth Group consolidated its existing pharmacy and care delivery services under a single brand. Optum operates through three segments: OptumHealth (care delivery), OptumInsight (data analytics and technology), and OptumRx (pharmacy benefits management). In fiscal year 2024, Optum's three segments generated combined revenues of approximately $257 billion, representing more than half of UnitedHealth Group's total $400.3 billion in revenues.
Parent Company
UnitedHealth Group
Founded
2011
Status
Publicly Traded
Headquarters
Minnetonka, Minnesota, USA
Who Owns Optum?
- Parent Company: UnitedHealth Group
- Ownership Type: Wholly owned
- Company Type: Publicly Traded
- Stock Ticker: NYSE: UNH
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Optum | UnitedHealth Group | Wholly owned |
History of Optum
- Founded: 2011
- Founders: UnitedHealth Group (internal consolidation)
Optum's history begins with the individual businesses that were consolidated under the Optum brand in 2011. UnitedHealth Group had been building healthcare services capabilities for many years before the Optum brand was created, through a combination of organic development and strategic acquisitions.
UnitedHealth Group's pharmacy benefits management business, which became OptumRx, had roots in the company's earlier pharmacy services operations. The company's health information technology business, which became OptumInsight, was built through acquisitions including the purchase of Ingenix, a healthcare data and analytics company, which UnitedHealth Group had operated since the 1990s. Ingenix was renamed OptumInsight when the Optum brand was launched in 2011.
The Optum brand was formally created in 2011 when UnitedHealth Group merged its existing pharmacy and care delivery services into a single unified platform. The consolidation was intended to create a more coherent healthcare services business that could compete more effectively with other large healthcare services companies and generate synergies across its different service lines.
Following the 2011 brand launch, Optum grew rapidly through a series of significant acquisitions. The company acquired Catamaran Corporation, a pharmacy benefits management company, in 2015 for approximately $12.8 billion, substantially expanding OptumRx's scale and capabilities. The Catamaran acquisition made OptumRx one of the three largest pharmacy benefits managers in the United States, alongside CVS Caremark and Express Scripts.
Optum continued its acquisition strategy in subsequent years, purchasing DaVita Medical Group in 2019 for approximately $4.9 billion, which significantly expanded OptumHealth's physician and care delivery capabilities. The DaVita Medical Group acquisition gave Optum a large network of primary care physicians and medical groups, accelerating the company's strategy of providing direct patient care rather than solely managing healthcare benefits.
In 2022, UnitedHealth Group completed the acquisition of Change Healthcare, a healthcare technology company, for approximately $13 billion. Change Healthcare was integrated into OptumInsight, adding significant healthcare payment processing and data analytics capabilities. However, in February 2024, Change Healthcare suffered a major cyberattack that disrupted healthcare payment processing across the United States for several weeks, affecting thousands of hospitals, pharmacies, and healthcare providers. The attack was attributed to the ALPHV/BlackCat ransomware group and was one of the most significant cyberattacks in U.S. healthcare history.
In 2023, UnitedHealth Group announced that it would acquire Amedisys, a home health and hospice company, for approximately $3.3 billion, further expanding OptumHealth's care delivery capabilities. The acquisition faced regulatory scrutiny from the Department of Justice, which filed suit to block the deal on antitrust grounds. The acquisition was ultimately terminated in 2024 following the DOJ's legal challenge.
About UnitedHealth Group
UnitedHealth Group operates through two primary platforms that work together to deliver comprehensive healthcare solutions: UnitedHealthcare and Optum. This integrated business model enables the company to serve the entire healthcare continuum, from insurance coverage to direct healthcare delivery and technology services, creating synergies that enhance both quality and efficiency.
UnitedHealthcare represents the company's health insurance and benefits division, providing coverage to individuals, employers, and government-sponsored programs including Medicare and Medicaid. In 2025, UnitedHealthcare served 49.8 million consumers and achieved revenues of $344.9 billion, representing 16% growth year-over-year. The division operates through multiple business segments including individual and family plans, employer-sponsored coverage, Medicare Advantage plans, and Medicaid managed care programs.
UnitedHealthcare's success stems from its extensive provider networks, innovative benefit designs, and focus on value-based care models. The company has developed sophisticated approaches to care coordination, preventive health programs, and chronic disease management that improve health outcomes while managing costs effectively. UnitedHealthcare's market leadership position enables it to negotiate favorable terms with healthcare providers and develop innovative insurance products that meet evolving consumer needs.
Optum delivers comprehensive healthcare services and technology solutions through three main segments that support the entire healthcare ecosystem:
Optum Health provides direct patient care and health services, operating clinics, surgical centers, and home health services. The segment employs healthcare professionals including physicians, nurses, and care coordinators who deliver integrated care to patients across various settings. Optum Health focuses on value-based care models that align financial incentives with health outcomes, creating more efficient and effective healthcare delivery systems.
Optum Insight offers data analytics, consulting, and technology services to healthcare organizations, payers, and life sciences companies. The segment leverages UnitedHealth Group's vast healthcare data assets to provide insights that improve clinical outcomes, reduce costs, and enhance operational efficiency. Optum Insight's services include population health management, revenue cycle optimization, and healthcare technology implementation.
Optum Rx manages pharmacy benefits for millions of people, negotiating with pharmaceutical manufacturers and managing prescription drug programs. In 2025, Optum Rx achieved 15% revenue growth, demonstrating strong performance in the pharmacy benefits management market. The segment combines purchasing power with clinical expertise to optimize medication therapy, improve adherence, and manage drug costs effectively.
UnitedHealth Group's integrated business model creates significant competitive advantages. The company's ability to combine insurance coverage with direct healthcare delivery enables better care coordination, improved health outcomes, and more efficient resource utilization. This integration also provides valuable data insights that inform product development, care management programs, and operational improvements.
In 2025, UnitedHealth Group demonstrated exceptional financial performance with consolidated revenues of $447.6 billion, representing 12% growth year-over-year. The company's adjusted earnings from operations reached $21.7 billion, reflecting strong operational execution despite challenges including cyberattack-related costs and business restructuring charges.
The company's financial metrics demonstrate operational efficiency and strong cash generation. UnitedHealth Group achieved cash flows from operations of $19.7 billion in 2025, representing 1.5 times net income. The company maintains a debt-to-capital ratio of 43.9% and targets a long-term ratio of 40.0%, reflecting prudent financial management.
UnitedHealth Group employs approximately 440,000 people worldwide, making it one of the largest employers in the healthcare industry. The company's workforce includes healthcare professionals, technology specialists, data analysts, and business professionals who support the company's integrated healthcare delivery model.
Looking toward 2026, UnitedHealth Group has established revenue guidance greater than $439.0 billion and adjusted earnings outlook greater than $17.75 per share. The company expects to continue its growth trajectory while addressing ongoing challenges including medical cost trends, regulatory changes, and competitive pressures in the healthcare market.
- Founded: 1977
- Headquarters: Minnetonka, Minnesota, USA
- Company Type: Publicly Traded
- Stock: NYSE: UNH
- Revenue: $447.6 billion (FY2025)
- Employees: Approximately 440,000
Where Is Optum Made / Based?
- Headquarters: Minnetonka, Minnesota, USA
- Manufacturing / Operations: United States
Optum Sustainability & Ethics
Optum operates under UnitedHealth Group's comprehensive sustainability framework, which addresses environmental responsibility, ethical business practices, and social impact across the healthcare industry. As a healthcare services platform, Optum's sustainability considerations encompass environmental impact reduction, health system improvement, responsible business practices, and community engagement in healthcare accessibility and outcomes.
ESG Reporting and Climate Action: Optum participates in UnitedHealth Group's comprehensive ESG reporting framework, following Sustainability Accounting Standards Board (SASB) guidelines for consistent disclosure of environmental, social, and governance information. The company has appointed a Chief Sustainability Officer to oversee day-to-day sustainability agenda through partnerships across Optum, UnitedHealthcare, Operations, and Facilities Management. Optum recognizes the impact of climate change on human health and is working to minimize its environmental footprint while helping people live healthier lives through targeted climate action initiatives.
Health System Improvement: Optum's core sustainability mission focuses on building a simpler, more consumer-oriented health system to help ensure everyone has access to high-quality, affordable healthcare. The company's "Built for Better Health" initiative serves as the foundation for long-term growth, fulfilling the mission of helping people live healthier lives and making the health system work better for everyone. This approach integrates sustainability directly into Optum's business model, creating measurable positive impact on community health outcomes.
Responsible Business Practices: Optum maintains ethical standards in healthcare delivery, data management, and business operations. The company adheres to comprehensive healthcare compliance frameworks and ethical business practices that prioritize patient privacy, data security, and fair treatment of all stakeholders. Optum's response to the February 2024 Change Healthcare cyberattack demonstrated the company's commitment to responsible crisis management, including the establishment of a Temporary Funding Assistance Program to help healthcare providers bridge cash flow gaps during the disruption.
Community Health Engagement: Optum maintains active community engagement programs that support healthcare accessibility, preventive care initiatives, and community wellness programs. The company's services extend beyond its insured members to serve external clients including other health insurers, employers, government agencies, and healthcare providers. Optum's community health initiatives focus on addressing social determinants of health, expanding access to care in underserved communities, and supporting preventive health programs that improve population health outcomes.
Environmental Impact Reduction: As part of UnitedHealth Group's broader sustainability efforts, Optum has implemented environmental impact reduction initiatives across its operations. The company utilizes energy-efficient facilities and has invested in renewable energy sources for its data centers and office locations. Optum's distribution logistics have been optimized to reduce transportation emissions, and the company has implemented comprehensive waste reduction and recycling programs across its operational facilities.
Awards & Recognition
Optum has received recognition for healthcare innovation, data analytics excellence, and contributions to health system improvement, particularly for its integrated care delivery model and technology-enabled healthcare solutions.
Healthcare Technology Recognition: OptumInsight's healthcare data analytics and technology platforms have received industry recognition for advancing healthcare data science and predictive analytics. The company's integration of Change Healthcare, despite the 2024 cyberattack challenges, has been acknowledged for creating comprehensive healthcare payment processing infrastructure that supports interoperability and data exchange across the healthcare system.
Care Delivery Innovation: OptumHealth's integrated care delivery model has received recognition from healthcare industry organizations for improving care coordination and patient outcomes. The company's physician group operations and care management programs have been acknowledged for demonstrating measurable improvements in healthcare quality metrics and cost-effectiveness compared to traditional fee-for-service models.
Pharmacy Benefits Management Excellence: OptumRx's pharmacy benefits management services have received recognition for innovation in medication management and cost containment strategies. The company's approximately 1.62 billion adjusted scripts processed in fiscal year 2024 demonstrate the scale and efficiency of its pharmacy operations, which have been acknowledged for creating significant value for healthcare payers and patients.
Crisis Management Recognition: Optum's response to the February 2024 Change Healthcare cyberattack received recognition from healthcare industry organizations for responsible crisis management and provider support. The company's rapid establishment of the Temporary Funding Assistance Program, which advanced over $2 billion in payments to affected healthcare providers, demonstrated exceptional commitment to maintaining healthcare system stability during unprecedented disruption.
Data Analytics and Research: Optum's healthcare research and data analytics initiatives have received recognition from medical and academic institutions for advancing evidence-based medicine and population health management. The company's contributions to healthcare data science have been acknowledged for creating actionable insights that improve treatment protocols and healthcare delivery strategies.
Optum Recalls & Controversies
Optum has faced several significant challenges and controversies throughout its history, particularly related to the February 2024 Change Healthcare cyberattack, regulatory scrutiny, and the complex dynamics of integrated healthcare delivery, reflecting the challenges of operating at scale in the modern healthcare system.
Change Healthcare Cyberattack (February 2024): The most significant challenge in Optum's history occurred in February 2024 when Change Healthcare, an OptumInsight subsidiary acquired for $13 billion in 2022, suffered a major ransomware cyberattack attributed to the ALPHV/BlackCat group. The attack disrupted healthcare payment processing across the United States for several weeks, affecting thousands of hospitals, pharmacies, and healthcare providers. The incident exposed significant cybersecurity vulnerabilities in Optum's technology infrastructure and resulted in substantial financial costs for UnitedHealth Group, including remediation expenses and payments to affected healthcare providers. The cyberattack was one of the most significant in U.S. healthcare history and led to congressional hearings and increased regulatory scrutiny.
Regulatory Scrutiny and Antitrust Concerns: Optum's vertical integration of insurance (UnitedHealthcare) and healthcare services has attracted increasing regulatory scrutiny from federal agencies. The Department of Justice successfully challenged UnitedHealth Group's proposed $3.3 billion acquisition of Amedisys in 2024 on antitrust grounds, signaling increased regulatory oversight of Optum's expansion through acquisitions. The terminated Amedisys deal reflected growing concerns about the potential for conflicts of interest and market concentration in vertically integrated healthcare organizations.
Pharmacy Benefits Management Controversies: OptumRx's role as a pharmacy benefits manager has been the subject of congressional scrutiny regarding drug pricing practices, rebate arrangements with pharmaceutical manufacturers, and potential conflicts of interest. Lawmakers have questioned whether PBMs create incentives that favor higher-priced medications over more affordable alternatives, potentially increasing healthcare costs for patients and payers.
Integration Complexity Challenges: Optum's rapid growth through acquisitions has created significant integration complexity, with the company managing a large portfolio of acquired businesses with different technology systems, cultures, and operational models. The integration of Change Healthcare, Catamaran Corporation, DaVita Medical Group, and other major acquisitions has required substantial investment in technology standardization and cultural alignment, creating ongoing operational challenges.
Data Privacy and Security Concerns: Beyond the major Change Healthcare cyberattack, Optum has faced ongoing challenges related to healthcare data privacy and security. The company's extensive collection and analysis of healthcare data creates inherent privacy risks, and Optum must navigate complex regulatory requirements under HIPAA and other healthcare privacy laws while maintaining effective data analytics capabilities.
Market Position and Competition Pressures: Optum operates in intensely competitive healthcare services markets, facing pressure from other large healthcare companies including CVS Health (through Aetna and MinuteClinic), Humana (through CenterWell), and various specialized healthcare technology companies. The company's dominant market position in pharmacy benefits management and healthcare payment processing has attracted competitive challenges and regulatory attention regarding market concentration.
Brands Owned by UnitedHealth Group
- Change Healthcare - UnitedHealth Group's healthcare technology and services company providing claims...
- Optum Health - UnitedHealth Group's healthcare delivery and value-based care division employing...
- Optum Insight - UnitedHealth Group's healthcare data analytics and technology division, which ac...
- UnitedHealthcare - UnitedHealth Group's health insurance brand providing coverage for individuals, ...
Optum Ownership: Pros & Cons
Advantages
- +Optum's scale across pharmacy benefits, care delivery, and health technology creates significant competitive advantages, as the combined platform can offer integrated solutions that smaller, specialized competitors cannot match
- +UnitedHealth Group's approximately 150 million insured members provide Optum's businesses with a large captive customer base that generates predictable revenue without requiring competitive bidding for each contract
- +OptumRx's approximately 1.62 billion adjusted scripts processed in 2024 give the pharmacy benefits management business significant purchasing leverage with pharmaceutical manufacturers, enabling competitive drug pricing for clients
- +OptumInsight's Change Healthcare acquisition, despite the 2024 cyberattack disruption, provides the business with a dominant position in healthcare payment processing infrastructure that is deeply embedded in the U.S. healthcare system
- +UnitedHealth Group's $400.3 billion in annual revenues provides Optum with investment capacity for technology development, acquisitions, and geographic expansion that smaller healthcare services companies cannot match
Considerations
- -The February 2024 cyberattack on Change Healthcare, an OptumInsight subsidiary, disrupted healthcare payment processing across the United States for several weeks and exposed significant cybersecurity vulnerabilities in Optum's technology infrastructure
- -Optum's vertical integration of insurance (UnitedHealthcare) and healthcare services (Optum) has attracted increasing regulatory scrutiny, with concerns that the combined entity has financial incentives to direct patients toward Optum's services even when alternatives might offer better outcomes
- -The Department of Justice's successful challenge to UnitedHealth Group's proposed acquisition of Amedisys in 2024 signals increased antitrust scrutiny of Optum's continued expansion through acquisitions
- -OptumRx's role as a pharmacy benefits manager has been the subject of congressional scrutiny regarding drug pricing practices, rebate arrangements with pharmaceutical manufacturers, and the potential for conflicts of interest
- -Optum's rapid growth through acquisitions has created integration complexity, with the company managing a large portfolio of acquired businesses with different technology systems, cultures, and operational models
Frequently Asked Questions About Optum
Sources & Further Reading
- Optum Official Website -
- UnitedHealth Group Corporate Website -
- UnitedHealth Group Investor Relations -
- UnitedHealth Group Sustainability Report -
- Change Healthcare Cyberattack Update -
- Optum Temporary Funding Assistance Program -
- American Academy of Ophthalmology -- Cyberattack Impact Analysis -
- American Hospital Association -- Cyberattack Response -
- Alliance Health Plan -- Provider Updates -
- Fierce Healthcare -- Cybersecurity Response -
- Sustainalytics -- ESG Risk Rating -
- CDP Climate Change Report -
- UHC Community -- Sustainability Progress -
- SEC Filings -- UnitedHealth Group Financial Reports and Risk Factors
- Healthcare Industry Publications -- Trade Analysis Reports
- Modern Healthcare -- Healthcare Business Analysis -
- Fierce Healthcare -- Payer and Provider News -
- Healthcare Dive -- Industry News and Analysis -
- Becker's Hospital Review -- Healthcare Management -- BeckersHospitalReview.com/
- Journal of Healthcare Management -- Academic Research -
- Health Affairs -- Health Policy Analysis -
Where to Buy
Disclosure: We may earn commission from purchasesCompetitors to Optum
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Cigna | USA | 1986 | Mass market | United states | All-ages | |
| Unitedhealth Group | USA | 2011 | Premium | United states | All-ages |
Learn More About Competitors

Express Scripts
Owned by The Cigna Group
One of the largest pharmacy benefits managers in the United States, owned by The Cigna Group and operating within its Evernorth Health Services division.

Optum Insight
Owned by UnitedHealth Group
UnitedHealth Group's healthcare data analytics and technology division, which acquired Change Healthcare for $13 billion in 2022 and generated $18.8 billion in 2024 revenue before a February 2024 ransomware attack disrupted U.S. healthcare payments.
Competitive Analysis
Market Positioning: Optum competes with 2 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
UnitedHealth Group Stock Information
Jobs at UnitedHealth Group
Latest News About Optum
Related Articles About Optum
View more articlesMonthly IPO Roundup: July 2026 — June's Biggest Listings
June 2026 was the most historic IPO month in market history: SpaceX priced at $135 per share on June 12, raising $75 billion in the largest IPO ever. Quantinuum raised $1.68B, INNIO priced a $2.8B deal, and Bending Spoons filed for a $20B Nasdaq listing. Full recap.
Monthly M&A Roundup: June 2026 Brand Ownership Changes
June 2026's biggest brand ownership moves: Berkshire Hathaway agreed to buy Taylor Morrison for $6.8B, GSK struck a $10.6B deal for Nuvalent, CRH acquired Arcosa for $8.5B, and Qualcomm agreed to buy AI startup Modular for $3.92B. Full breakdown of every major deal.
A Complete Guide to LVMH Brands: What Does the Luxury Giant Own?
LVMH owns 75 luxury maisons including Louis Vuitton, Dior, Tiffany, Guerlain, and Sephora. Here is the complete brand list by division, with acquisition dates and what each brand does.
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Accutane
Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Activase
Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.

Acuvue
Acuvue is the world's leading contact lens brand, owned by Johnson & Johnson Vision Care, a division of Johnson & Johnson. The brand covers daily, weekly, and monthly disposable soft contact lenses sold in more than 100 countries.